M+W Group Promotes Smart Lab Design at the Asia Pharma R&D Leaders Summit 2017
(Thomson Reuters ONE) -
M+W Group /
M+W Group Promotes Smart Lab Design at the Asia Pharma R&D Leaders Summit 2017
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Shanghai/China, 28 March 2017
M+W Group was invited as a thought leadership company to participate in the Asia
Pharma R&D Leaders Summit 2017, a key pharma R&D event in China, being held in
Shanghai, China.
There, M+W Group's Lead Process Architecture Manager and Laboratory Planner in
China, Mr. Mark Stephens, presented to the executive level scientific delegates
on "Smart Lab Design" which allows R&D facilities to be built faster, be
adaptable, cheaper, safer, greener and more productive.
In his presentation the M+W expert explained that often laboratory design
focuses too much on being "fully flexible" which can be very expensive, rather
than aiming to be "adaptable" and capabable of easy reconfiguration. Here, M+W
Group's smart lab design solutions focus on creating an environment that is more
energy efficient and has better use of floor and research space thus creating a
more productive environment and overall a more cost effective solution. This
involves adopting open plan layouts, using isolation technology and clean
bubbles to house experiments, creating a harmonious and stimulating working
environment, using pre-assembled modules, mobile laboratory furniture,
relocatable partitions, plug and play technology, and just-in-time solutions
which all alleviate wasted space, duplication and down-time and offer better
safety and suitability for the needs of the scientists.
Mark Stephens says "By thinking about laboratory facilities with an
interdisciplinary mind, we can design and construct the most perfect asset for
our clients that will reduce carbon emissions, be cheaper, more efficient,
faster to construct, adaptive, more productive, safer and overall will create an
alluring environment to stimulate innovation and collaboration."
The Asia Pharma R&D Leaders Summit 2017 was held on 21st and 22nd March, 2017
with a full program of thought provoking and educational pharma and
biotechnology topics related to Neurodegenerative Diseases; Cancer, Diabetes and
Metabolic Diseases where large pharma multi-nationals and others are heavily
investing in R&D throughout Asia.
About M+W Group: M+W Group GmbH, based in Stuttgart/Germany, is a leading global
high-tech engineering company. Established in 1912, the company operates in more
than 30 countries. The M+W Group manages projects of all dimensions on behalf of
clients from various sectors, including electronics, chemicals and
pharmaceuticals, energy and information technology - from semiconductor plants
to nanotechnology research centers. The company offers a full range of services
from concept and design to turnkey solutions. During the financial year 2015,
the M+W Group generated sales of ~3.0 billion euros with around 6,000 employees
worldwide. For more information please visit: www.mwgroup.net.
Press contact Asia-Pacific:
Natalie Grice
Phone +61 432 497 907
E-Mail: natalie.grice(at)mwgroup.net
Press contact Global:
Christoph Jag
Phone: +49 711 8804-2193
E-Mail: christoph.jag(at)mwgroup.net
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: M+W Group via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 28.03.2017 - 17:45 Uhr
Sprache: Deutsch
News-ID 532971
Anzahl Zeichen: 3982
contact information:
Town:
Stuttgart
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 349 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"M+W Group Promotes Smart Lab Design at the Asia Pharma R&D Leaders Summit 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
M+W Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
